EGFR Tyrosine Kinase Inhibitor Efficacy in Older Adult Patients with Advanced EGFR-Mutated Non-Small-Cell Lung Cancer: A Meta-Analysis and Systematic Review

Background and Objectives: Lung cancer remains the most common malignancy worldwide. As the global population ages, the prevalence of epidermal growth factor receptor (EGFR)-mutation-positive non-small cell lung cancer (NSCLC) is increasing. Materials and Methods: We performed a meta-analysis and a...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Chang-Hung, Chou, Deng-Wei, Chung, Kuo-Mou, Chang, Han-Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9698818/
https://www.ncbi.nlm.nih.gov/pubmed/36422186
http://dx.doi.org/10.3390/medicina58111645

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9698818/
https://www.ncbi.nlm.nih.gov/pubmed/36422186
http://dx.doi.org/10.3390/medicina58111645

Ejemplares similares